In the second quarter of this year, Teamwork Financial Advisors LLC has increased its position in Intuitive Surgical, Inc. by 9.7%. The firm now owns 20,603 shares of the medical equipment provider’s stock, representing a 1.1% stake in the company and making it their 16th largest position. This recent acquisition brings the total value of Teamwork Financial Advisors LLC’s holdings in Intuitive Surgical to $7,045,000.
Intuitive Surgical (NASDAQ:ISRG) recently released its quarterly earnings data on July 20th. The company reported earnings per share of $1.42 for the quarter, surpassing analyst expectations by $0.09. Its revenue stood at $1.76 billion for the same period, slightly exceeding the projected $1.74 billion.
The positive financial results are reflective of Intuitive Surgical’s strong performance and growth trajectory. Its return on equity stands at an impressive 12.41%, while its net margin reached an equally notable 21.38%. Furthermore, the company experienced a significant increase of 15.4% in revenue compared to the previous year’s quarter.
Analysts within the sell-side project that Intuitive Surgical, Inc.’s positive momentum will persist throughout the current fiscal year as they predict earnings per share of approximately 4.53.
These encouraging figures make Intuitive Surgical an attractive investment opportunity for firms like Teamwork Financial Advisors LLC. With consistent growth and strong financial performance, the company is positioned as one of the leading players in the medical equipment industry.
As we move further into 2023, investors will be closely monitoring Intuitive Surgical’s continued success and any future developments that may impact its market standing and stock performance.
Disclaimer: The information provided here is solely for informational purposes and should not be considered as financial advice or a recommendation to invest in any particular security or market sector.
Major Investment Changes and Positive Outlook for Intuitive Surgical
Intuitive Surgical, the renowned medical equipment provider, has recently seen significant changes in its ownership as several hedge funds and institutional investors have made adjustments to their positions in the company. One notable change includes HHM Wealth Advisors LLC increasing its holdings in Intuitive Surgical by a staggering 1,314.3% during the first quarter. This move resulted in HHM Wealth Advisors owning 99 shares of Intuitive Surgical’s stock, valued at $25,000 after acquiring an additional 92 shares.
Similarly, Bogart Wealth LLC saw a substantial increase of 721.4% in its stake in Intuitive Surgical during the same period. This led to Bogart Wealth now owning 115 shares worth $29,000 after purchasing an additional 101 shares. Barrett & Company Inc., on the other hand, entered the scene as a newcomer by acquiring a new position worth $30,000.
Strategic Investment Solutions Inc. IL also took advantage of the opportunities presented by Intuitive Surgical and purchased a new position during the first quarter valued at $39,000. Furthermore, Addison Advisors LLC witnessed significant growth in its holdings by an astounding 1,837.5% during this period. As a result, Addison Advisors now owns 155 shares of Intuitive Surgical’s stock worth $40,000 after acquiring an additional 147 shares.
It is worth noting that hedge funds and institutional investors collectively own approximately 82.91% of Intuitive Surgical’s stock as reported recently.
Numerous research firms have weighed in on ISRG with their own evaluations of the company’s performance and potential future outlooks. For instance, JPMorgan Chase & Co.’s research report recommended giving Intuitive Surgical an “overweight” rating and raised its price objective from $335.00 to $365.00 on July 21st.
Raymond James also expressed an optimistic stance by upping their price target for Intuitive Surgical from $323.00 to $368.00 and labeling the stock as “outperform” in a research report on July 24th. Robert W. Baird gave an “outperform” rating and a price objective of $377.00, while Piper Sandler raised its target price from $315.00 to $385.00, both providing positive outlooks.
To add to the ratings, BTIG Research also shared its positive sentiments by increasing its price target from $326.00 to $373.00 in a report on July 17th.
According to Bloomberg.com, Intuitive Surgical currently holds an average rating of “Moderate Buy,” with analysts projecting an average price target of $343.10 for the company’s stock.
In other news related to Intuitive Surgical, Director Alan J. Levy conducted a transaction by selling 2,000 shares of the company’s stock on August 7th at an average price of $310.00 per share, resulting in a total value of $620,000. Following this sale, Levy now possesses 25,319 shares valued at approximately $7,848,890.
Director Amy L. Ladd also sold 500 shares of Intuitive Surgical’s stock on September 14th at an average price of $305.68 per share for a total transaction value of $152,840. After completing the transaction, Ladd now holds 702 shares worth around $214,587.
Insiders in the company have sold a cumulative total of 60,309 shares within the last three months alone which amounts to approximately $19,649,321.
Intuitive Surgical’s stock recently traded at $288.20 during trading hours on Friday and had a trading volume of 1,962,444 shares compared to its average volume of 1,503,711 shares traded daily.
With a one-year low of $180.07 and a one-year high of $358.07, Intuitive Surgical currently stands within this range. The stock also maintains a 50-day moving average price of $309.25 and a 200-day moving average price of $299.71.
Intuitive Surgical’s market capitalization is estimated at $101.27 billion, with a price-to-earnings ratio of 72.23 and a price-to-earnings-growth ratio of 4.05. Its beta sits at 1.30, indicative of its slightly higher volatility compared to the broader market.
Overall, Intuitive Surgical has experienced notable changes in ownership with hedge funds and institutional investors making significant moves in their positions in the company. Analysts have given favorable ratings to the stock and have raised their price targets accordingly, signaling positive growth potential for the company going forward.
Discussion about this post